본문 바로가기
KERD
논문KCI 등재

Transcriptional regulation of Glis2 in hepatic fibrosis

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

The role of Gli-similar 2 (Glis2) in hepatic fibrosis (HF) is controversial. In this study, we focused on the functional and molecular mechanisms involved in the Glis2-mediated activation of hepatic stellate cells (HSCs)—a milestone event leading to HF. The expression levels of Glis2 mRNA and protein were significantly decreased in the liver tissues of patients with severe HF and in mouse fibrotic liver tissues as well as HSCs activated by TGFβ1. Functional studies indicated that upregulated Glis2 significantly inhibited HSC activation and alleviated BDL-induced HF in mice. Downregulation of Glis2 was found to correlate significantly with DNA methylation of the Glis2 promoter mediated by methyltransferase 1 (DNMT1), which restricted the binding of hepatic nuclear factor 1-α (HNF1-α), a liver-specific transcription factor, to Glis2 promoters. In addition, the enrichment of DNMT1 in the Glis2 promoter region was mediated by metastasis-associated lung adenocarcinoma transcriptor-1 (MALAT1) lncRNA, leading to transcriptional silencing of Glis2 and activation of HSCs. In conclusion, our findings reveal that the upregulation of Glis2 can maintain the resting state of HSCs. The decreased expression of Glis2 under pathological conditions may lead to the occurrence and development of HF with the expression silencing of DNA methylation mediated by MALAT1 and DNMT1.

Abstract

The role of Gli-similar 2 (Glis2) in hepatic fibrosis (HF) is controversial. In this study, we focused on the functional and molecular mechanisms involved in the Glis2-mediated activation of hepatic stellate cells (HSCs)—a milestone event leading to HF. The expression levels of Glis2 mRNA and protein were significantly decreased in the liver tissues of patients with severe HF and in mouse fibrotic liver tissues as well as HSCs activated by TGFβ1. Functional studies indicated that upregulated Glis2 significantly inhibited HSC activation and alleviated BDL-induced HF in mice. Downregulation of Glis2 was found to correlate significantly with DNA methylation of the Glis2 promoter mediated by methyltransferase 1 (DNMT1), which restricted the binding of hepatic nuclear factor 1-α (HNF1-α), a liver-specific transcription factor, to Glis2 promoters. In addition, the enrichment of DNMT1 in the Glis2 promoter region was mediated by metastasis-associated lung adenocarcinoma transcriptor-1 (MALAT1) lncRNA, leading to transcriptional silencing of Glis2 and activation of HSCs. In conclusion, our findings reveal that the upregulation of Glis2 can maintain the resting state of HSCs. The decreased expression of Glis2 under pathological conditions may lead to the occurrence and development of HF with the expression silencing of DNA methylation mediated by MALAT1 and DNMT1.

참고문헌 (39)

  1. Aydin, M. M., "Liver fibrosis", Turk. J. Gastroenterol, 29, pp.14~21 (2018)
  2. Pellicoro, A., "Liver fibrosis and repair : immune regulation of wound healing in a solid organ", Nat. Rev. Immunol, 14, pp.181~194 (2014)
  3. Trivella, J. P., "Novel targeted therapies for the management of liver fibrosis", Expert Opin. Emerg. Drugs, 25, pp.59~70 (2020)
  4. Jiang, J. X, "Liver injury and the activation of the hepatic myofibroblasts", Curr. Pathobiol. Rep, 1, pp.215~223 (2013)
  5. Zhang, F., "Characterization of Glis2, a novel gene encoding a Gli-related, Kruppel-like transcription factor with transactivation and repressor functions. Roles in kidney development and neurogenesis", J. Biol. Chem, 277, pp.10139~10149 (2002)
  6. Kang, H. S., "Gli-similar(Glis)Kruppel-like zinc finger proteins : insights into their physiological functions and critical roles in neonatal diabetes and cystic renal disease", Histol. Histopathol, 25, pp.1481~1496 (2010)
  7. Lichti-Kaiser, K., "Gli-similar proteins : their mechanisms of action, physiological functions, and roles in disease", Vitam. Horm, 88, pp.141~171 (2012)
  8. Senee, V., "Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism", Nat. Genet, 38, pp.682~687 (2006)
  9. Attanasio, M., "Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis", Nat. Genet, 39, pp.1018~1024 (2007)
  10. Kim, Y. S., "Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions", Mol. Cell Biol, 28, pp.2358~2367 (2008)
  11. Loft, A., "Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication", Cell Metab, 33, pp.1685~1700 (2021)
  12. Bian, E. B., "DNA methylation : new therapeutic implications for hepatic fibrosis", Cell Signal, 25, pp.355~358 (2013)
  13. He, Z., "The Roles and Mechanisms of lncRNAs in Liver Fibrosis", Int. J. Mol. Sci (2020)[DOI]
  14. Peng, H., "The roles of lncRNA in hepatic fibrosis", Cell Biosci, 8, pp.63~ (2018)
  15. Dai, X., "Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite", Toxicol. Lett, 316, pp.73~84 (2019)
  16. Leti, F., "Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells", Transl. Res, 190, pp.25~39 (2017)
  17. Yu, F., "MALAT1 functions as a competing endogenous RNA to mediate Rac1expression by sequestering miR-101b in liver fibrosis", Cell Cycle, 14, pp.3885~3896 (2015)
  18. Zhao, Y., "Nuclear-encoded lncRNA MALAT1 epigenetically controls metabolic reprogramming in HCC cells through the mitophagy pathway", Mol. Ther. Nucleic Acids, 23, pp.264~276 (2021)
  19. "Retraction of: MALAT1-driven inhibition of wnt signal impedes proliferation and inflammation in fibroblast-like synoviocytes through CTNNB1 promoter methylation in rheumatoid arthritis", Hum. Gene Ther (2021)[DOI]
  20. Zhang, J., "TGFbeta1induced autophagy activates hepatic stellate cells via the ERK and JNK signaling pathways", Int. J. Mol. Med, 47, pp.256~266 (2021)
  21. Bhogal, R. H., "Isolation of primary human hepatocytes from normal and diseased liver tissue : a one hundred liver experience", PLoS One, 6, pp.e18222~ (2011)
  22. Tag, C. G., "Bile duct ligation in mice : induction of inflammatory liver injury and fibrosis by obstructive cholestasis", J. Vis. Exp (2015)[DOI]
  23. Maschmeyer, P., "Seven steps to stellate cells", J. Vis. Exp (2011)[DOI]
  24. Zhang, K., "SCARNA10, a nuclear-retained long non-coding RNA, promotes liver fibrosis and serves as a potential biomarker", Theranostics, 9, pp.3622~3638 (2019)
  25. Bian, E. B., "New advances of DNA methylation in liver fibrosis, with special emphasis on the crosstalk between microRNAs and DNA methylation machinery", Cell Signal, 25, pp.1837~1844 (2013)
  26. De Carvalho, D. D., "DNA methylation and cellular reprogramming", Trends Cell Biol, 20, pp.609~617 (2010)
  27. Tang, J., "Bidirectional transcription of Linc00441 and RB1 via H3K27modification-dependent way promotes hepatocellular carcinoma", Cell Death Dis, 8, pp.e2675~ (2017)
  28. Cheng, D., "LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation", EBioMed, 36, pp.159~170 (2018)
  29. Sun, Z., "Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma", Oncogene, 39, pp.6906~6919 (2020)
  30. Li, T., "SET1A cooperates with CUDR to PROMOTE LIVER CANCER GROWTH AND HEPATOCYTE-LIKE STEM CELL MALIGNANT TRANSFORMATION EPIGENetically", Mol. Ther, 24, pp.261~275 (2016)
  31. Li, Q., "AS1DHRS4, a head-to-head natural antisense transcript, silences the DHRS4 gene cluster in cis and trans", Proc. Natl. Acad. Sci. USA, 109, pp.14110~14115 (2012)
  32. Sui, C. J., "Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b", a, J. Mol. Med. (Berl. ), pp.2016, 94[DOI]
  33. Gui, X., "Long noncoding RNA CUDR regulates HULC and beta-catenin to govern human liver stem cell malignant differentiation", Mol. Ther, 23, pp.1843~1853 (2015)
  34. Parola, M., "Liver fibrosis : Pathophysiology, pathogenetic targets and clinical issues", Mol. Aspects Med, 65, pp.37~55 (2019)
  35. Delgado, M. E., "Metabolic reprogramming of liver fibrosis", Cells (2021)[DOI]
  36. Heberle, E., "Sensitivity of transcription factors to DNA methylation", Essays Biochem, 63, pp.727~741 (2019)
  37. Vasanth, S., "Identification of nuclear localization, DNA binding, and transactivating mechanisms of Kruppel-like zinc finger protein Gli-similar 2(Glis2)", J. Biol. Chem, 286, pp.4749~4759 (2011)
  38. Pinto, K., "Gene of the month : GLIS1-3", J. Clin. Pathol, 73, pp.527~530 (2020)
  39. Yasuoka, Y., "Evolutionary history of GLIS genes illuminates their roles in cell reprograming and ciliogenesis", Mol. Biol. Evol, 37, pp.100~109 (2020)

관련 논문AI추천

Erratum : Transcriptional regulation of Glis2 in hepatic fibrosisChen Li-Min, Gong Huan-Yu, Liu Zhen-Guo, Zhang Hao-Ye, Zhou Peng-Cheng, Zhou Yang-Mei생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Long non-coding RNAs: key regulators of liver and kidney fibrogenesis박종훈, Eun Seo Kang, Je Yeong Ko, Kyung Hyun Yoo, Su-hyang Han생화학분자생물학회 · BMB Reports2023 · 제56권 제7호Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition김성민, 김정희, 윤승규, 이은별, 이준호, 이천주, 최정은, 허원희, 홍성우거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제1호Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis박수연, 유정윤, 윤호근, Hyunsik Kim, Jae-Hwan Kwon, Mi Jeong Kim, Seunghee Byun, Soo Yeon Lee, Sungryul Yu생화학분자생물학회 · BMB Reports2023 · 제56권 제2호A Disintegrin and Metalloprotease with Thrombospondin Motif 2 May Contribute to Cirrhosis in Humans through the Transforming Growth Factor-β/SMAD PathwayChao Dong, Han-Jun Li, Hui-Huan Tang, Hui-Jun Liao, Peng Huang, Shi Chang, Zhi-Peng Zhang거트앤리버 소화기연관학회협의회 · Gut and Liver2013 · 제7권 제2호JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosisChang Liu, Hui Chen, Jia Ding, Jian Wu, Li Xie, Li Zhang, Qiang Yang, Xiao Teng, Xiu-Ping Liu, Ya-Jun Yan, Yong-Yu Yang, Yuan Zhou, Yue Ma, Yu-Li Wang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호

이 간행물의 다른 논문 (225건)